New York, September 06, 2013 -- Moody's Investors Service assigned a (P)Baa3 senior unsecured shelf rating to Edwards Lifesciences Corporation ("Edwards"). This is a first time rating for this manufacturer of medical devices aimed at treating heart valve disease. The rating outlook is stable.
Vollständigen Artikel bei Moodys lesen